Market Size of North America Over the Counter Drugs Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 2.70 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
North America Over the Counter Drugs Market Analysis
The North America Over the Counter (OTC) Drugs Market is anticipated to grow with a CAGR of 2.7%, during the forecast period.
The OTC drugs market is innovation-driven and relies on the advent of innovative drugs for different disease complexities and vary in their degree of intensity, and efficacy. The product innovations in OTC drugs have built confidence among the consumers and have resulted in the increased demand for OTC drugs. Although the market share is high in the North American region, the USA's share is less when compared to the other countries on a global forefront. This can be due to the strict regulatory measures taken by the US government in the labelling of drugs as OTC. But in recent times, there has been a change in opinion regarding the OTC market. The potential benefits have been identified and as a result, OTC drugs have been made more accessible.
According to the Consumer Healthcare Products Association, 2019, it was estimated that about 93% of the Americans prefer to treat their minor ailments with OTC medicines before seeking professional care. For the treatment of musculoskeletal injuries and disorders, many patients in the United States generally use nonprescription topical analgesics. Counterirritants are approved by the FDA for the topical treatment of minor pains and muscle and joint aches and are often used for the treatment of acute musculoskeletal injuries, such as simple backache, arthritis pain, strains, bruises, and sprains. Thus, owing to above factors the market is expected to show growth over the forecast period.
North America Over the Counter Drugs Industry Segmentation
As per the scope of this report, over the counter drugs are referred to as non-prescription drugs. These medicines can be bought by an individual without the doctor's prescription and are safe for consumption without the doctor's consent. North America over the counter drugs market is segmented by product type, distribution channel, and geography.
| By Product Type | |
| Cough, Cold, and Flu Products | |
| Analgesics | |
| Dermatology Products | |
| Gastrointestinal Products | |
| Vitamins, Mineral, and Supplements (VMS) | |
| Weight-loss/Dietary Products | |
| Ophthalmic Products | |
| Sleeping Aids | |
| Other Product Types |
| By Distribution Channel | |
| Hospital Pharmacies | |
| Retail Pharmacies | |
| Online Pharmacy | |
| Other Distribution Channels |
| Geography | |||||
|
North America Over the Counter Drugs Market Size Summary
The North America Over the Counter (OTC) Drugs Market is poised for growth, driven by innovation and increased consumer confidence in OTC products. The market is characterized by the introduction of new drugs addressing various health issues, which has boosted demand. Despite the high market share in North America, the United States lags behind other countries globally due to stringent regulatory measures governing OTC drug labeling. However, recent shifts in perception have made OTC drugs more accessible, with a significant portion of the American population preferring OTC solutions for minor health issues. This trend is particularly evident in the use of nonprescription topical analgesics for musculoskeletal injuries, which are approved by the FDA for treating minor pains and aches.
The market is expected to see substantial growth, particularly in the weight-loss and dietary products segment, driven by heightened health awareness and the prevalence of lifestyle-related diseases. The Vitamins, Minerals, and Supplements (VMS) segment holds the largest market share, supported by a broad customer base seeking preventive health solutions. The fragmented nature of the market sees major players like Johnson and Johnson, Novartis AG, Bayer AG, Sanofi, and Pfizer dominating, while mid-size and smaller companies leverage technological advancements and product innovations to expand their presence. The high demand and revenue generation in this sector are fueled by the large customer pools and the popularity of VMS products in developed regions, indicating promising growth prospects in the coming years.
North America Over the Counter Drugs Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Product Innovations
-
1.2.2 Inclination of Pharmaceutical Companies Toward OTC Drugs from RX Drugs
-
-
1.3 Market Restraints
-
1.3.1 Probability of Substance Abuse
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Product Type
-
2.1.1 Cough, Cold, and Flu Products
-
2.1.2 Analgesics
-
2.1.3 Dermatology Products
-
2.1.4 Gastrointestinal Products
-
2.1.5 Vitamins, Mineral, and Supplements (VMS)
-
2.1.6 Weight-loss/Dietary Products
-
2.1.7 Ophthalmic Products
-
2.1.8 Sleeping Aids
-
2.1.9 Other Product Types
-
-
2.2 By Distribution Channel
-
2.2.1 Hospital Pharmacies
-
2.2.2 Retail Pharmacies
-
2.2.3 Online Pharmacy
-
2.2.4 Other Distribution Channels
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
-
North America Over the Counter Drugs Market Size FAQs
What is the current North America Over the Counter Drugs Market size?
The North America Over the Counter Drugs Market is projected to register a CAGR of 2.70% during the forecast period (2024-2029)
Who are the key players in North America Over the Counter Drugs Market?
Sanofi, Johnson and Johnson, Novartis AG, Pfizer Inc and Bayer AG are the major companies operating in the North America Over the Counter Drugs Market.
